Avenue Therapeutics Inc. buy melinda
Start price
14.12.21
/
50%
€13.28
Target price
14.12.22
€0.000
Performance (%)
-99.89%
End price
20.02.22
€0.015
Summary
This prediction ended on 20.02.22 with a price of €0.015. The BUY prediction by melinda for Avenue Therapeutics Inc. performed very badly with a performance of -99.89%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avenue Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to melinda what are the pros and cons of Avenue Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Avenue Therapeutics diskutieren
Buy mit Kursziel 0,0
In the thread Trading Avenue Therapeutics
Buy beendet
Stopped prediction by melinda for Avenue Therapeutics Inc.
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.63
14.10.22
14.10.22
€5.00
14.10.23
14.10.23
-84.59%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.015
20.02.22
20.02.22
€7.50
20.03.22
20.03.22
61900.00%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.95
11.11.21
11.11.21
€30.00
11.11.22
11.11.22
-21.68%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year